Advertisement
Kura Oncology, Inc. (KURA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 10.06 |
| Open | 10.27 |
| Bid | 10.75 x 100 |
| Ask | 10.89 x 100 |
| Day's Range | 9.95 - 11.17 |
| 52 Week Range | 9.06 - 24.17 |
| Volume | |
| Avg. Volume | 858,296 |
| Market Cap | 839.849M |
| Beta (5Y Monthly) | 0.86 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.35 |
| Earnings Date | Nov 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.57 |
BioPharma DiveHalozyme drops Evotec buyout bid; Patient dies in Neurogene trial
Evotec appears to have rebuffed Halozyme’s $2.1 billion acquisition attempt. Elsewhere, Argenx has another blockbuster target in sight and an FDA veteran plans retirement.
Investor's Business DailyKura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover
Kura Oncology slammed the door on its takeover narrative Thursday, inking a deal for its leukemia drug. Kura stock crashed.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.